Acute otitis media is a bacterial infection of the middle ear behind the ear drum which causes it to become painfully inflamed.
Three out of four children experience this infection within their first year. Consequently, it is the most common reason why children are prescribed an antibiotic.
Researchers from University of Pittsburgh Medical Centre (UPMC) in the US studied 520 children between 9 and 23 months of age with acute otitis media.
Children with acute otitis media were randomly assigned to either a standard 10-day regimen of the antibiotic amoxicillin-clavulanate or a shortened 5-day treatment followed by five days of placebo.
Neither the study participants nor the physicians knew which group the participant was assigned to.
Children were followed starting in October through the rest of the annual respiratory-infection season and had a final visit during the following September.
The results were significant, since the trial design was set up to find out whether the five-day treatment would be as good as the 10-day regimen, said Hoberman.
Instead, researchers found that not only was their initial assumption proven wrong, but the 10-day treatment was far more effective.
When they tested the presence of antibiotic-resistant bacteria through nasopharyngeal (back of the nose) swabs, there was no decrease in the five-day group as might have been expected with a shorter duration of antibiotics.
When testing the risk of a recurrent infection, they found that it was higher when children were exposed to three or more children for 10 or more hours per week, such as in a day care setting, or if the initial infection occurred in both ears as opposed to just one ear.
The study also showed for the first time that almost one in two children in whom residual fluid was observed in the middle ear after treatment had a recurring infection, a significantly higher percentage when compared to children without any residual fluid in the middle ear.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
